Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GSK3B | P49841 | 4/20 | 0.46 |
| ▸ | PTP4A3 | O75365 | 2/20 | 0.42 |
| ▸ | PARP1 | P09874 | 1/20 | 0.42 |
| ▸ | PTGS2 | P35354 | 5/20 | 0.42 |
| ▸ | PTP4A2 | Q12974 | 1/20 | 0.40 |
| ▸ | PTP4A1 | Q93096 | 1/20 | 0.40 |
| ▸ | CASP3 | P42574 | 1/20 | 0.39 |
| ▸ | CASP2 | P42575 | 1/20 | 0.39 |
| ▸ | CASP7 | P55210 | 1/20 | 0.39 |
| ▸ | CASP6 | P55212 | 1/20 | 0.39 |
| ▸ | CASP8 | Q14790 | 1/20 | 0.39 |
| ▸ | MAOA | P21397 | 2/20 | 0.38 |
| ▸ | MAOB | P27338 | 2/20 | 0.38 |
| ▸ | BRAF | P15056 | 1/20 | 0.37 |
| ▸ | ADK | P55263 | 1/20 | 0.36 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30570525 | 0.88 | PTP4A3 (0.39) | GSK3BPTP4A3PARP1PTGS2PTP4A2 | |
| SCHEMBL5949251 | 0.87 | PTP4A3 (0.39) | GSK3BPTP4A3PARP1PTGS2PTP4A2 | |
| SCHEMBL1133537 | 0.83 | PTGS2 (0.57) | GSK3BPTGS2 | |
| SCHEMBL1246496 | 0.82 | MEN1 (0.36) | GSK3BPTP4A3PTGS2MAOAMAOB | |
| Adipic Acid SCHEMBL31357385 | 0.79 | F13A1 (0.43) | PTGS2CASP3NPSR1 | |
| Nitrogen SCHEMBL7672060 | 0.78 | JAK2 (0.43) | GSK3BPTP4A3PARP1PTGS2PTP4A2 | |
| SCHEMBL7132790 | 0.74 | PTGS2 (0.44) | GSK3BPTGS2 | |
| SCHEMBL9016868 | 0.74 | GSK3B (0.50) | GSK3BPTP4A3PARP1PTP4A2PTP4A1 | |
| SCHEMBL8767001 | 0.72 | GSK3A (0.58) | GSK3BMAOAMAOB | |
| SCHEMBL28274474 | 0.71 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 63 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-115768752-B | Substituted isophthalic acid diamides | 拜耳公司 | 2025-04-22 | — | — | CN | claimed |
| CN-119463260-A | Method for modifying hydrophilic polyelectrolyte multilayer film on surface of hydrophobic polymer particles by using coating machine | 刘洪江 | 2025-02-18 | — | — | CN | claimed |
| CN-115884967-A | Substituted isophthalic acid diamides | 拜耳公司 | 2023-03-31 | — | — | CN | claimed |
| CN-115768752-A | Substituted isophthalic acid diamides | 拜耳公司 | 2023-03-07 | — | — | CN | claimed |
| CN-115745871-A | Synthesis method of N, N' -bis (2, 6-tetramethyl-4-piperidyl) -1, 3-benzenedicarboxamide | 江苏极易新材料有限公司 | 2023-03-07 | — | — | CN | claimed |
| WO-2022088300-A1 | PREPARATION METHOD FOR M-PHENYLENEDIAMINE | 山东兴强化工产业技术研究院有限公司 | 2022-05-05 | — | — | WO | claimed |
| WO-2022088301-A1 | METHOD FOR SYNTHESIZING M-PHENYLENEDIAMINE | 山东兴强化工产业技术研究院有限公司 | 2022-05-05 | — | — | WO | claimed |
| WO-2022088303-A1 | METHOD FOR PREPARING M-PHENYLENEDIAMINE | 山东兴强化工产业技术研究院有限公司 | 2022-05-05 | — | — | WO | claimed |
| WO-2022088302-A1 | PREPARATION METHOD FOR ISOPHTHALAMIDE | 山东兴强化工产业技术研究院有限公司 | 2022-05-05 | — | — | WO | claimed |
| EP-1272223-B1 | THERAPEUTIC AND DIAGNOSTIC LIGAND SYSTEMS COMPRISING TRANSPORT MOLECULE BINDING PROPERTIES AND MEDICAMENTS CONTAINING THE SAME | KTB TUMORFORSCHUNGS GMBH (DE) | 2006-05-31 | — | — | EP | claimed |
| US-4780535-A | Maleic and phthalic diamides | THEODOROPULOS SPYROS (US) | 1988-10-25 | — | — | US | claimed |
| US-20260148876-A1 | CONDUCTIVE PARTICLES, CONDUCTIVE MATERIALS USED THE SAME | DUK SAN NEOLUX CO., LTD. (KR) | 2026-05-28 | — | — | US | disclosed |
| CN-122091300-A | Conductive particle, conductive material, and connection structure | — | 2026-05-26 | — | — | CN | disclosed |
| EP-4572795-A2 | METHODS AND COMPOSITIONS FOR TREATING CANCER WITH CANCER-BINDING ADJUVANTS | The University of Chicago (US) | 2025-06-25 | — | — | EP | disclosed |
| CN-119984574-A | Pressure sensor and preparation method thereof | 深圳大学 | 2025-05-13 | — | — | CN | disclosed |
| US-4743691-A | INHIBITORS OF ORNITHINE DECARBOXYLASE | MERRELL DOW FRANCE ET CIE (FR) | 1988-05-10 | — | — | US | disclosed |
| EP-0046710-B1 | PREPARATION OF AMINOACETONITRILE DERIVATIVES | MERRELL TORAUDE ET COMPAGNIE (FR) | 1984-06-13 | — | — | EP | disclosed |
| US-4405530-A | Process for preparing fluorinated amino-nitriles | MERRELL TORAUDE ET COMPAGNIE (FR) | 1983-09-20 | — | — | US | disclosed |
| EP-0046710-A1 | Preparation of aminoacetonitrile derivatives | MERRELL TORAUDE ET COMPAGNIE (FR) | 1982-03-03 | — | — | EP | disclosed |
| US-4179444-A | Process for the manufacture of iso-imides or mixtures of iso-imides and imides | CIBA-GEIGY CORPORATION (US) | 1979-12-18 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260148876-A1 | CONDUCTIVE PARTICLES, CONDUCTIVE MATERIALS USED THE SAME | NOXO1, SCO2, CAD | GSK3B 1381/4885PTP4A3 578/4885PARP1 1771/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.